Live Breaking News & Updates on Safia Chatur

Stay updated with breaking news from Safia chatur. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Cardiology Month in Review: April 2024

The April 2024 cardiology month in review spotlights FDA news and top updates from the American College of Cardiology 2024 Scientific Session. ....

United States , Deepak Bhatt , Abbott Triclip , Safia Chatur , Drug Administration Abbott Esprit , Drug Administration , American College Of Cardiology , Circulatory System Devices Panel , American College , Scientific Sessions , Drug Administration Abbott , Eluting Resorbable Scaffold System , New England Journal , Mount Sinai Heart , Valentin Foster Professor , Cardiovascular Medicine , Annual Scientific , Young Investigator , Danger Shock ,

Safia Chatur, MD: Sacubitril/Valsartan Offers Benefit in HFrEF Across New KDIGO Risk Classes

Safia Chatur, MD, discusses the results of a PARADIGM-HF analysis at ACC.24 examining the effects of ARNI use across the updated 2024 KDIGO Risk Classifications. ....

United States , Safia Chatur , Coll Cardiol , Work Group , American College Of Cardiology , American College , Annual Scientific Sessions , Disease Improving Global Outcomes , Massachusetts General Hospital , Hazard Ratio , Confidence Interval , Valsartan Across , Renal Impairment , Patients With Heart , Improving Global Outcomes , Practice Guideline , Chronic Kidney ,

Safia Chatur, MD: Effect of Dapagliflozin on Worsening Heart Failure

A secondary analysis of the DELIVER trial found dapagliflozin significantly reduced the full spectrum of worsening heart failure events, including outpatient oral diuretic intensification. ....

United States , Safia Chatur , European Society Of Cardiology Congress , Harvard Medical School , European Society , Cardiology Congress , Massachusetts General Hospital ,